Skip to main content
HR 2410 115th Congress House Health Blood and blood diseases Health care coverage and access Health information and medical records Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Minority health Research administration and funding

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

Introduced: May 11, 2017 Introduced by: Davis, Danny K. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb 26, 2018
Motion to reconsider laid on the table Agreed to without objection.
Feb 26, 2018
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)
Feb 26, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)
Feb 26, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.
Feb 26, 2018
Considered under suspension of the rules. (consideration: CR H1240-1243)
Feb 26, 2018
Mr. Burgess moved to suspend the rules and pass the bill.
Oct 19, 2017
Placed on the Union Calendar, Calendar No. 258.
Oct 19, 2017
Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
Jun 7, 2017
Ordered to be Reported by Voice Vote.
Jun 7, 2017
Committee Consideration and Mark-up Session Held.
May 18, 2017
Forwarded by Subcommittee to Full Committee by Voice Vote .
May 18, 2017
Subcommittee Consideration and Mark-up Session Held.
May 12, 2017
Referred to the Subcommittee on Health.
May 11, 2017
Referred to the House Committee on Energy and Commerce.
May 11, 2017
Introduced in House
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.

(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
What's happening now February 27, 2018

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3